HomeCompareOBMP vs PLD

OBMP vs PLD: Dividend Comparison 2026

OBMP yields 128.21% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBMP wins by $5.09M in total portfolio value
10 years
OBMP
OBMP
● Live price
128.21%
Share price
$1.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.60M
Annual income
$4,575,129.27
Full OBMP calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — OBMP vs PLD

📍 OBMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBMPPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBMP + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBMP pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBMP
Annual income on $10K today (after 15% tax)
$10,897.44/yr
After 10yr DRIP, annual income (after tax)
$3,888,859.88/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $579,110.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBMP + PLD for your $10,000?

OBMP: 50%PLD: 50%
100% PLD50/50100% OBMP
Portfolio after 10yr
$9.05M
Annual income
$4,915,782.72/yr
Blended yield
54.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

OBMP
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBMP buys
0
PLD buys
0
No recent congressional trades found for OBMP or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBMPPLD
Forward yield128.21%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$11.60M$6.50M
Annual income after 10y$4,575,129.27$5,256,436.18
Total dividends collected$10.60M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: OBMP vs PLD ($10,000, DRIP)

YearOBMP PortfolioOBMP Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$23,521$12,820.51$11,255$555.24+$12.3KOBMP
2$53,349$28,181.78$13,062$1,018.59+$40.3KOBMP
3$116,823$59,739.54$15,903$1,926.67+$100.9KOBMP
4$247,259$122,259.11$20,839$3,823.32+$226.4KOBMP
5$506,405$241,837.18$30,464$8,166.08+$475.9KOBMP
6$1,004,750$462,896.88$52,054$19,457.30+$952.7KOBMP
7$1,933,425$858,342.70$109,886$54,188.93+$1.82MOBMP
8$3,612,406$1,543,641.03$304,030$186,451.18+$3.31MOBMP
9$6,560,727$2,695,452.74$1,166,125$840,813.32+$5.39MOBMP
10$11,595,107$4,575,129.27$6,504,190$5,256,436.18+$5.09MOBMP

OBMP vs PLD: Complete Analysis 2026

OBMPStock

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.

Full OBMP Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this OBMP vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBMP vs SCHDOBMP vs JEPIOBMP vs OOBMP vs KOOBMP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.